Mainstream News

Johnson & Johnson’s 1-dose shot prevents COVID-19, but less than 2-dose competitors

Johnson & Johnson’s 1-dose shot prevents COVID-19,
but less than 2-dose competitors 1

It’s not clear exactly how well the AstraZeneca version, being used in Britain and several other countries, works. Tests in Britain, South Africa and Brazil suggested two doses are about 70% effective although there are questions about how much protection older adults get. An ongoing U.S. study may provide more information.

Read the Full Article

Mainstream News

Prepare Now Before its too Late

Discover where products are available & compare prices

Letters: Revise mask advice | Bumbling bureaucracy | Lottery limits | Saving face
The Debate Over Reopening Schools

You might also like
Menu